Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tfelt-Hansen

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
Neuroepidemiology|January 1, 1985
Methodological aspects of drug trials in migraineP Tfelt-Hansen, J Olesen
Cephalalgia : an International Journal of Headache|March 1, 1981
Ergotamine abuse. Do patients benefit from withdrawal?P Tfelt-Hansen, A Krabbe
Neuroepidemiology|January 1, 1987
Patient numbers needed in prophylactic migraine trialsP Tfelt-Hansen, S L Nielsen
Ugeskrift for Laeger|January 27, 2000
[Etiology of migraine]M B Russell, P Tfelt-Hansen
Acta Pharmacologica Et Toxicologica|September 1, 1984
Dose-response curve for the ergotamine-induced decrease of peripheral systolic blood pressure in manP Tfelt-Hansen, P M Manniche
Functional Neurology|October 1, 1986
Methodology of drug trials in migraineP Tfelt-Hansen, S L Nielsen
Pharmacology & Toxicology|September 1, 1993
No effect of the 5HT2-antagonist ICI 169,369 on systolic, ergotamine-induced blood pressure changes in manT H Nielsen, P Tfelt-Hansen
Neurology|April 24, 1999
Naratriptan is effective and well tolerated in the acute treatment of migraineP Tfelt-Hansen, P J Goadsby
Clinical Physiology (Oxford, England)|February 1, 1982
Local regulation of subcutaneous blood flow in normal subjects and in migraine patients before and after single-dose ergotamine tartrateJ H Eickhoff, P Tfelt-Hansen
Neurology|November 23, 2000
Oral therapy for migraine: comparisons between rizatriptan and sumatriptan. A review of four randomized, double-blind clinical trialsP Tfelt-Hansen, R E Ryan
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
Neuroepidemiology|January 1, 1985
Methodological aspects of drug trials in migraineP Tfelt-Hansen, J Olesen
Cephalalgia : an International Journal of Headache|March 1, 1981
Ergotamine abuse. Do patients benefit from withdrawal?P Tfelt-Hansen, A Krabbe
Neuroepidemiology|January 1, 1987
Patient numbers needed in prophylactic migraine trialsP Tfelt-Hansen, S L Nielsen
Ugeskrift for Laeger|January 27, 2000
[Etiology of migraine]M B Russell, P Tfelt-Hansen
Acta Pharmacologica Et Toxicologica|September 1, 1984
Dose-response curve for the ergotamine-induced decrease of peripheral systolic blood pressure in manP Tfelt-Hansen, P M Manniche
Functional Neurology|October 1, 1986
Methodology of drug trials in migraineP Tfelt-Hansen, S L Nielsen
Pharmacology & Toxicology|September 1, 1993
No effect of the 5HT2-antagonist ICI 169,369 on systolic, ergotamine-induced blood pressure changes in manT H Nielsen, P Tfelt-Hansen
Neurology|April 24, 1999
Naratriptan is effective and well tolerated in the acute treatment of migraineP Tfelt-Hansen, P J Goadsby
Clinical Physiology (Oxford, England)|February 1, 1982
Local regulation of subcutaneous blood flow in normal subjects and in migraine patients before and after single-dose ergotamine tartrateJ H Eickhoff, P Tfelt-Hansen
Neurology|November 23, 2000
Oral therapy for migraine: comparisons between rizatriptan and sumatriptan. A review of four randomized, double-blind clinical trialsP Tfelt-Hansen, R E Ryan
Pageof 12